Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,001,400 | 2,077,300 | 1,909,100 | 2,023,200 | 1,824,200 |
| Cost of Goods | 559,300 | 592,200 | 549,800 | 586,700 | 538,600 |
| Gross Profit | 1,442,100 | 1,485,100 | 1,359,300 | 1,436,500 | 1,285,600 |
| Operating Expenses | 1,091,100 | 1,185,300 | 1,067,800 | 1,048,100 | 1,006,700 |
| Operating Income | 351,300 | 300,000 | 292,300 | 389,000 | 279,500 |
| Interest Expense | 75,400 | 79,300 | 66,200 | 61,900 | 54,300 |
| Other Income | 3,300 | 3,900 | 2,900 | -38,100 | 5,100 |
| Pre-tax Income | 279,200 | 224,600 | 229,000 | 289,000 | 230,300 |
| Income Tax | 48,000 | 71,200 | 46,500 | 48,900 | -18,900 |
| Net Income Continuous | 231,200 | 153,400 | 182,500 | 240,100 | 249,200 |
| Minority Interests | 300 | 600 | 600 | 600 | 200 |
| Net Income | $230,900 | $152,800 | $182,000 | $239,500 | $249,000 |
| EPS Basic Total Ops | 1.17 | 0.77 | 0.92 | 1.20 | 1.23 |
| EPS Basic Continuous Ops | 1.17 | 0.78 | 0.92 | 1.19 | 1.23 |
| EPS Diluted Total Ops | 1.16 | 0.77 | 0.91 | 1.18 | 1.23 |
| EPS Diluted Continuous Ops | 1.16 | 0.77 | 0.91 | 1.19 | 1.23 |
| EPS Diluted Before Non-Recurring Items | 1.90 | 2.07 | 1.81 | 2.31 | 1.74 |
| EBITDA(a) | $634,900 | $571,800 | $546,700 | $652,700 | $530,400 |